Browsing by Author "Lim, Darren Wan-Teck"
Now showing items 1-3 of 3
-
First-in-human phase I/Ib open-label dose-escalation study of GWN323 (anti-GITR) as a single agent and in combination with spartalizumab (anti-PD-1) in patients with advanced solid tumors and lymphomas
Piha-Paul, Sarina; Geva, Ravit; Tan, Tira; Lim, Darren Wan-Teck; Hierro Carbó, Cinta; Doi, Toshikiko (BMJ, 2021-08) -
Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial
Schuler, Martin; Berardi, R.; Lim, Darren Wan-Teck; de Jonge, M.; Azaro Pedrazzoli, Analía Beatriz; Bauer, Todd (Elsevier, 2020-06) -
Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts
Su, Wu-Chou; Schuler, Martin; Nam, Do-Hyun; Lim, Darren Wan-Teck; Azaro Pedrazzoli, Analía Beatriz; Bauer, Todd; Bang, Yung-Jue (Wiley, 2020-02)